期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Clinical characteristics predicting erythema nodosum leprosum(ENL) among patients with multibacillary leprosy(MBL) in Sarawak
1
作者 Yap Felix Boon Bin 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2009年第5期66-70,共5页
Objective:To determine the clinical features predicting erythema nodosum leprosum(ENL) in a non endemic leprosy area.Methods:Twenty newly diagnosed patients with MBL attending the skin clinic,Sarawak General Hospital ... Objective:To determine the clinical features predicting erythema nodosum leprosum(ENL) in a non endemic leprosy area.Methods:Twenty newly diagnosed patients with MBL attending the skin clinic,Sarawak General Hospital from 1992 to 2007 were analyzed.They were divided into 2 groups,one with ENL and one without. Analysis of the presenting clinical features was done to determine the risk factors for ENL.Chi square and student t test was used for statistical analysis.Level of significance was set at 0.05.Results:ENL was present in 40%patients,all with lepromatous leprosy(LL).Clinical features that were seen more frequently in patients developing ENL include earlobe thickening(100%cf.25%,P =0.00),loss of the lateral third of the eyebrows(75%cf.16.7%,P=0.02) and mean bacteriology index(BI)(5.1 cf.2.9,P=0.03) and mean morphological index(MI)(17.8 cf.7.0,P =0.02).Number of thickened nerves(mean 2.5 cf. 1.4,P = 0.12),number of skin lesions(mean 19.4 cf.10.9,P = 0.15) and duration of illness(mean 15. 3 cf.12.8 months,P =0.68) did not predict ENL development.Conclusion:Finding LL patients with thickened earlobes,loss of lateral third of the eyebrow,high BI and MI should alert treating clinician to the possibility of ENL in a non endemic leprosy area. 展开更多
关键词 LEPROSY erythema nodosum leprosum(ENL) Multibacillary LEPROSY
下载PDF
Efficacy and Safety of Prednisolone Monotherapy Versus Prednisolone Plus Methotrexate in Erythema Nodosum Leprosum (Type 2 Lepra Reaction)
2
作者 Hasan Zahidul Mowla Mohammad Rafiqul +1 位作者 Angkur Debashish Mondol Khan Md. Ismail 《International Journal of Dermatology and Venereology》 2020年第4期205-210,共6页
Objective:This study was performed to compare the efficacy and safety of methotrexate(MTX)plus prednisolone versus prednisolone monotherapy in patients with erythema nodosum leprosum(ENL).Methods:This comparative clin... Objective:This study was performed to compare the efficacy and safety of methotrexate(MTX)plus prednisolone versus prednisolone monotherapy in patients with erythema nodosum leprosum(ENL).Methods:This comparative clinical study was performed in the Chittagong Medical College Hospital,Bangladesh from June 2018 to December 2019.Nineteen patients were selected according to inclusion criteria and randomly allocated to either the MTX plus prednisolone group(Group A,n=10)or the prednisolone monotherapy group(Group B,n=9).All patients were followed up until the end of the 6-month duration of therapy to observe the clinical outcomes and adverse effects.Results:All patients in both groups showed significant improvement(P=0.005 and P=0.008 in Group A and B,respectively).However,prednisolone-related adverse events were more frequent in Group B.Conclusion:The present study has demonstrated that a combination of prednisolone and MTX is a safer and more effective treatment than steroid monotherapy in ENL patients including the healing of nodules.However,this combination therapy did not appear to have a significant steroid-sparing effect,possibly because of the small sample size and short study period.Therefore,a well-designed multicenter randomized controlled trial is recommended for validation of MTX with prednisolone for the management of ENL. 展开更多
关键词 erythema nodosum leprosum type 2 lepra reaction METHOTREXATE PREDNISOLONE BANGLADESH
原文传递
Type 2 reaction associated sensorineural hearing loss in a drug resistant lepromatous leprosy patient: A case report
3
作者 Harpreet Singh Pawar Itu Singh Harish Kumar Sagar 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2023年第9期425-427,I0001,共4页
Rationale:Leprosy,a chronic granulomatous disease often present clinically as erythema nodosum leprosum,a type 2 reaction.The involvement of cochlear part of audiovestibular system is a rarity.Patient concerns:A 26-ye... Rationale:Leprosy,a chronic granulomatous disease often present clinically as erythema nodosum leprosum,a type 2 reaction.The involvement of cochlear part of audiovestibular system is a rarity.Patient concerns:A 26-year-old male patient with lepromatous leprosy developed bilateral sensorineural hearing loss(SNHL)during type 2 reactional episode.Diagnosis:Recurrent erythema nodosum leprosum in rifampicin-resistant lepromatous leprosy.Interventions:Corticosteroids and second-line multidrug therapy.Outcomes:The patient improved significantly and was further referred for management of psychosocial impact due to sensorineural hearing loss.Lessons:The hearing impairment is a rare complication of type 2 reaction.Any patient with suspected cranial nerve involvement should essentially be screened by tuning fork tests for early detection of hearing impairment and offer timely intervention as required.All high bacteriological index cases should be investigated for antimicrobial resistance in high endemic areas. 展开更多
关键词 Leprosy reactions erythema nodosum leprosum Sensorineural hearing loss Drug resistant leprosy
下载PDF
雷公藤多甙治疗麻风结节性红斑的疗效观察 被引量:8
4
作者 沈建平 周敏 +3 位作者 严良斌 杨荣德 胡廷应 茆青松 《皮肤性病诊疗学杂志》 2013年第3期164-168,共5页
目的:评价雷公藤多甙对麻风结节性红斑(erythema nodosun leprosun,ENL)的疗效和副作用。方法:采用开放性研究,将入选的34例患者分成雷公藤多甙单独治疗组(A组,18例)及皮质类固醇和雷公藤多甙联合治疗组(B组,16例)。A组患者口服雷公藤多... 目的:评价雷公藤多甙对麻风结节性红斑(erythema nodosun leprosun,ENL)的疗效和副作用。方法:采用开放性研究,将入选的34例患者分成雷公藤多甙单独治疗组(A组,18例)及皮质类固醇和雷公藤多甙联合治疗组(B组,16例)。A组患者口服雷公藤多甙60~80 mg/天,治疗4周,然后停药或减量出院继续治疗2~4周;B组治疗方法为在A组基础上加服皮质类固醇。结果:治疗4周后,临床平均评分显示,A组18例患者从疗前的10.94下降到0.94;B组16例患者从疗前的13.19下降到1.63。两组分别在治疗2周时即见到临床改善,与治疗前比较差异有统计学意义(P值均<0.01)。尽管两组在药物减量或停药后都有患者出现ENL复发,但是症状较轻,与疗前相比,差异仍有统计学意义(P<0.01)。结论:雷公藤多甙在治疗麻风2型反应方面有显著疗效,药物副作用轻微,但需要制定出一个缓慢减量的治疗方案以控制ENL复发。 展开更多
关键词 麻风 雷公藤多甙 结节性红斑
下载PDF
重症难治性麻风结节性红斑1例死亡病例报告 被引量:1
5
作者 石超 杨德刚 +1 位作者 朱建宇 景志春 《中国医学文摘(皮肤科学)》 2017年第3期364-366,共3页
患者男,22岁。四肢反复出现结节性红斑,左肘关节、腕关节疼痛,并伴有发热、乏力6年。8年前在麻风防治机构被确诊为界限类偏瘤型麻风(BL),予联合化疗(MDT)治疗2年。查体:面部散在浸润性红斑,四肢大量疼痛性红色结节,肘、腕关节肿胀压痛;... 患者男,22岁。四肢反复出现结节性红斑,左肘关节、腕关节疼痛,并伴有发热、乏力6年。8年前在麻风防治机构被确诊为界限类偏瘤型麻风(BL),予联合化疗(MDT)治疗2年。查体:面部散在浸润性红斑,四肢大量疼痛性红色结节,肘、腕关节肿胀压痛;两侧尺神经粗大,无触痛。皮肤组织液涂片抗酸杆菌均(+),细菌指数(BI)4.0。皮损组织病理示:表皮下有"无浸润带",真皮内有巨噬细胞肉芽肿,可见泡沫细胞,抗酸染色阳性。诊断:BL伴Ⅱ型麻风反应。终因治疗无效死亡。尸检提示颅内感染。 展开更多
关键词 麻风反应 麻风结节性红斑 治疗
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部